AXISCADES appoints Dr. Sampath Ravinarayanan as Non-Executive Director
Dr. Ravinarayanan, who is a prominent figure in the Indian aerospace and defence sector, has a career spanning over four decades in the industry.
AXISCADES Technologies Ltd, a technology and engineering solutions provider, has appointed Dr. Sampath Ravinarayanan as a Non-Executive Director on its Board.
Dr. Ravinarayanan, who is a prominent figure in the Indian aerospace and defence sector, has a career spanning over four decades in the industry. He previously served as the CEO and Chairman of AXISCADES Technologies Ltd. until 2014, where he was instrumental in securing and implementing the Airbus Fuselage Development Centre contract.
During his tenure, he also spearheaded the Mirage2000 midlife extension project in collaboration with Thales International and MBDA, France, and founded Microcon Instruments and Systems in 1983, which became one of the first private companies in India to participate in defence programs. He was awarded a Doctor of Philosophy degree honoris causa by the National Institute of Technology, Kurukshetra, in 2020.
"I look forward to supporting the team in delivering futuristic solutions that align with India’s strategic objectives," said Dr. Sampath Ravinarayanan.
"We are pleased to welcome Dr. Ravinarayanan back to the Board. . His unique ability to bridge the gap between government policies, international partnerships, and private-sector agility will be critical as we continue to push the boundaries of what we can achieve."
RELATED ARTICLES
Lumax Auto Technologies to Acquire Remaining 25% Stake in IAC India
The proposed acquisition will make IAC India a wholly owned subsidiary of Lumax Auto Technologies, strengthening its pos...
Hyundai to Accelerate EV Push, Plans to Launch Six New Models by FY30
Electric vehicles accounted for just 1% of Hyundai’s total sales portfolio, with 3,969 EVs sold in FY25.
Hyundai India to Grow in Line with Market in FY26; Targets 7–8% Export Growth; Invest Rs 7000 crore
To roll out 8 new models in the near term; Hybrids confirmed as part of future-ready strategy.